826
Views
1
CrossRef citations to date
0
Altmetric
Review

Treatment of acute exacerbations of interstitial lung disease

, , &
Pages 309-313 | Received 30 Nov 2017, Accepted 26 Feb 2018, Published online: 12 Mar 2018

References

  • Azadeh N, Limper AH, Carmona EM, et al. The role of infection in interstitial lung diseases: a review. Chest. 2017 Oct;152(4):842–852. PubMed PMID: 28400116. DOI:10.1016/j.chest.2017.03.033
  • Collard HR, Moore BB, Flaherty KR, et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2007 Oct 01;176(7):636–643. PubMed PMID: 17585107; PubMed Central PMCID: PMCPMC2094133. DOI:10.1164/rccm.200703-463PP
  • Huie TJ, Olson AL, Cosgrove GP, et al. A detailed evaluation of acute respiratory decline in patients with fibrotic lung disease: aetiology and outcomes. Respirology. 2010;15(6):909–917. PubMed PMID: 20546190.
  • Arcadu A, Moua T. Bronchoscopy assessment of acute respiratory failure in interstitial lung disease. Respirology. 2017 Feb;22(2):352–359. PubMed PMID: 27712021. DOI:10.1111/resp.12909
  • Collard HR, Ryerson CJ, Corte TJ, et al. Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report. Am J Respir Crit Care Med. 2016 Aug 1;194(3):265–275. PubMed PMID: 27299520; English. DOI:10.1164/rccm.201604-0801CI
  • Collard HR, Yow E, Richeldi L, et al. Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials. Respir Res. 2013 Jul 13;14:73. PubMed PMID: 23848435; PubMed Central PMCID: PMCPMC3729659. DOI:10.1186/1465-9921-14-73
  • Song JW, Hong SB, Lim CM, et al. Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur Respir J. 2011 Feb;37(2):356–363. PubMed PMID: 20595144.
  • Moua T, Westerly BD, Dulohery MM, et al. Patients with fibrotic interstitial lung disease hospitalized for acute respiratory worsening: a large cohort analysis. Chest. 2016 May;149(5):1205–1214. PubMed PMID: 26836940; English.
  • Mura M, Porretta MA, Bargagli E, et al. Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study. Eur Respir J. 2012 Jul;40(1):101–109. PubMed PMID: 22241745. DOI:10.1183/09031936.00106011
  • Ohshimo S, Ishikawa N, Horimasu Y, et al. Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosis. Respir Med. 2014 Jul;108(7):1031–1039. PubMed PMID: 24835074. DOI:10.1016/j.rmed.2014.04.009
  • Kondoh Y, Taniguchi H, Katsuta T, et al. Risk factors of acute exacerbation of idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis: Official Journal of WASOG/World Association of Sarcoidosis and Other Granulomatous Disorders. 2010 Jul;27(2):103–110. PubMed PMID: 21319592.
  • Judge EP, Fabre A, Adamali HI, et al. Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Eur Respir J. 2012 Jul;40(1):93–100. PubMed PMID: 22135282. DOI:10.1183/09031936.00115511
  • Johannson KA, Vittinghoff E, Lee K, et al. Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure. Eur Respir J. 2014 Apr;43(4):1124–1131. PubMed PMID: 24176998; PubMed Central PMCID: PMCPMC5555605. DOI:10.1183/09031936.00122213
  • Reichmann WM, Yu YF, Macaulay D, et al. Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis. BMC Pulm Med. 2015 Dec 29;15:167. PubMed PMID: 26714746; PubMed Central PMCID: PMCPMC4696269. DOI:10.1186/s12890-015-0161-5
  • Daniels CE, Yi ES, Ryu JH. Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis. Eur Respir J. 2008 Jul;32(1):170–174. PubMed PMID: 18256070. DOI:10.1183/09031936.00176307
  • Stewart JP, Egan JJ, Ross AJ, et al. The detection of Epstein-Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 1):1336–1341. PubMed PMID: 10194186. DOI:10.1164/ajrccm.159.4.9807077
  • Tang YW, Johnson JE, Browning PJ, et al. Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis. J Clin Microbiol. 2003 Jun;41(6):2633–2640. PubMed PMID: 12791891; PubMed Central PMCID: PMCPMC156536.
  • Simon-Blancal V, Freynet O, Nunes H, et al. Acute exacerbation of idiopathic pulmonary fibrosis: outcome and prognostic factors [comparative study]. Respiration. 2012;83(1):28–35. PubMed PMID: 21860222.
  • Lee JS, Collard HR, Anstrom KJ, et al. Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials. The Lancet Respir Med. 2013 Jul;1(5):369–376. PubMed PMID: 24429201; PubMed Central PMCID: PMCPMC4059609. DOI:10.1016/S2213-2600(13)70105-X
  • Bando M, Ohno S, Hosono T, et al. Risk of acute exacerbation after video-assisted thoracoscopic lung biopsy for interstitial lung disease. J Bronchology Interv Pulmonol. 2009 Oct;16(4):229–235. PubMed PMID: 23168584. DOI:10.1097/LBR.0b013e3181b767cc
  • Ghatol A, Ruhl AP, Danoff SK. Exacerbations in idiopathic pulmonary fibrosis triggered by pulmonary and nonpulmonary surgery: a case series and comprehensive review of the literature. Lung. 2012 Aug;190(4):373–380. PubMed PMID: 22543997. DOI:10.1007/s00408-012-9389-5
  • Oda K, Ishimoto H, Yamada S, et al. Autopsy analyses in acute exacerbation of idiopathic pulmonary fibrosis. Respir Res. 2014 Sep 1;15:109. PubMed PMID: 25176016; PubMed Central PMCID: PMCPMC4243719. DOI:10.1186/s12931-014-0109-y
  • Hutchinson JP, Fogarty AW, McKeever TM, et al. In-hospital mortality after surgical lung biopsy for interstitial lung disease in the United States. 2000 to 2011. Am J Respir Crit Care Med. 2016 May 15;193(10):1161–1167. PubMed PMID: 26646481. DOI:10.1164/rccm.201508-1632OC
  • Maher TM, Whyte MKB, Hoyles RK, et al. Development of a consensus statement for the definition, diagnosis, and treatment of acute exacerbations of idiopathic pulmonary fibrosis using the delphi technique [Research Support, Non-U.S. Gov’t]. Adv Ther. 2015;32(10):929–943. PubMed PMID: 26498943; PubMed Central PMCID: PMCPMC4635174.
  • Saydain G, Islam A, Afessa B, et al. Outcome of patients with idiopathic pulmonary fibrosis admitted to the intensive care unit. Am J Respir Crit Care Med. 2002 Sep 15;166(6):839–842. PubMed PMID: 12231494. DOI:10.1164/rccm.2104038
  • Atkins CP, Loke YK, Wilson AM. Outcomes in idiopathic pulmonary fibrosis: a meta-analysis from placebo controlled trials. Respir Med. 2014 Feb;108(2):376–387. PubMed PMID: 24440032. DOI:10.1016/j.rmed.2013.11.007
  • Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011 Mar 15;183(6):788–824. PubMed PMID: 21471066; PubMed Central PMCID: PMCPMC5450933. DOI:10.1164/rccm.2009-040GL
  • Fumeaux T, Rothmeier C, Jolliet P. Outcome of mechanical ventilation for acute respiratory failure in patients with pulmonary fibrosis. Intensive Care Med. 2001 Dec;27(12):1868–1874. PubMed PMID: 11797021. DOI:10.1007/s00134-001-1150-0
  • Stern JB, Mal H, Groussard O, et al. Prognosis of patients with advanced idiopathic pulmonary fibrosis requiring mechanical ventilation for acute respiratory failure. Chest. 2001 Jul;120(1):213–219. PubMed PMID: 11451841.
  • Mollica C, Paone G, Conti V, et al. Mechanical ventilation in patients with end-stage idiopathic pulmonary fibrosis. Respiration. 2010;79(3):209–215. PubMed PMID: 19546508. DOI:10.1159/000225932
  • Rush B, Wiskar K, Berger L, et al. The use of mechanical ventilation in patients with idiopathic pulmonary fibrosis in the United States: a nationwide retrospective cohort analysis. Respir Med. 2016 Feb;111:72–76. PubMed PMID: 26733227. DOI:10.1016/j.rmed.2015.12.005
  • Kondoh Y, Cottin V, Brown KK. Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis. Eur Respir Rev: Official Journal of the European Respiratory Society. 2017 Sep 30;26(145):170050. PubMed PMID: 28954766.
  • Oda K, Yatera K, Fujino Y, et al. Efficacy of concurrent treatments in idiopathic pulmonary fibrosis patients with a rapid progression of respiratory failure: an analysis of a national administrative database in Japan. BMC Pulm Med. 2016;16(1):91. PubMed PMID: 27278093; PubMed Central PMCID: PMCPMC4898301. English. DOI:10.1186/s12890-016-0253-x
  • Kawamura K, Ichikado K, Suga M, et al. Efficacy of azithromycin for treatment of acute exacerbation of chronic fibrosing interstitial pneumonia: a prospective, open-label study with historical controls. Respiration. 2014;87(6):478–484. PubMed PMID: 24802885.
  • Kushi H, Miki T, Okamaoto K, et al. Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation. Crit Care. 2005;9(6):R653–61. PubMed PMID: 16280061; PubMed Central PMCID: PMCPMC1414001. DOI:10.1186/cc3815
  • Abe S, Azuma A, Mukae H, et al. Polymyxin B-immobilized fiber column (PMX) treatment for idiopathic pulmonary fibrosis with acute exacerbation: a multicenter retrospective analysis [Research Support, Non-U.S. Gov’t]. Intern Med. 2012;51(12):1487–1491. PubMed PMID: 22728479.
  • Tsushima K, Kubo K, Koizumi T, et al. Direct hemoperfusion using a polymyxin B immobilized column improves acute respiratory distress syndrome. J Clin Apher. 2002;17(2):97–102. PubMed PMID: 12210714. DOI:10.1002/jca.10019
  • Donahoe M, Valentine VG, Chien N, et al. Autoantibody-targeted treatments for acute exacerbations of idiopathic pulmonary fibrosis. PLoS One. 2015;10(6):e0127771. PubMed PMID: 26083430; PubMed Central PMCID: PMCPMC4470587. DOI:10.1371/journal.pone.0127771
  • Kataoka K, Taniguchi H, Kondoh Y, et al. Recombinant human thrombomodulin in acute exacerbation of idiopathic pulmonary fibrosis. Chest. 2015 Aug;148(2):436–443. PubMed PMID: 25811735. DOI:10.1378/chest.14-2746
  • Tsushima K, Yamaguchi K, Kono Y, et al. Thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis: a proof of concept study. Pulm Pharmacol Ther. 2014 Dec;29(2):233–240. PubMed PMID: 24836398. DOI:10.1016/j.pupt.2014.04.008
  • Horita N, Akahane M, Okada Y, et al. Tacrolimus and steroid treatment for acute exacerbation of idiopathic pulmonary fibrosis. Intern Med. 2011;50(3):189–195. PubMed PMID: 21297319.
  • Ding J, Chen Z, Feng K. Procalcitonin-guided antibiotic use in acute exacerbations of idiopathic pulmonary fibrosis. PubMed PMID: 23781136; PubMed Central PMCID: PMCPMC3675504 Int J Med Sci. 2013;107:903–907. DOI:10.7150/ijms.4972
  • Shulgina L, Cahn AP, Chilvers ER, et al. Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomised controlled trial. Thorax. 2013 Feb;68(2):155–162. PubMed PMID: 23143842. DOI:10.1136/thoraxjnl-2012-202403
  • Richeldi L, Costabel U, Selman M, et al. Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med. 2011 Sep 22;365(12):1079–1087. PubMed PMID: 21992121. DOI:10.1056/NEJMoa1103690
  • Mizuno Y, Iwata H, Shirahashi K, et al. The importance of intraoperative fluid balance for the prevention of postoperative acute exacerbation of idiopathic pulmonary fibrosis after pulmonary resection for primary lung cancer. Eur J Cardiothorac Surg. 2012 Jun;41(6):e161–5. PubMed PMID: 22504895. DOI:10.1093/ejcts/ezs147

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.